-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
-
Summary
-
ELITE PHARMACEUTICALS INC /NV/ quarterly Deferred Income Tax Assets, Net history and change rate from Q1 2022 to Q3 2025.
- ELITE PHARMACEUTICALS INC /NV/ Deferred Income Tax Assets, Net for the quarter ending 30 Sep 2025 was $11,804,166.000, a 43.4% decline year-over-year.
Deferred Income Tax Assets, Net, Quarterly (USD)
Deferred Income Tax Assets, Net, YoY Quarterly Change (%)